NSPR InspireMD, Inc.
InspireMD, Inc. (NSPR) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 0% planned / 100% discretionary
Largest single sale: $28.6K.
Where they traded
Last open-market purchase: May 27, 2026 , by Stuka Paul .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Stuka Paul | Director | Buy | 20,000 | $0.88 | $17.5K | 667,871 | |
| Gleason Shane Thomas | Chief Commercial Officer | Sell | 22,778 | $1.01 | $23.0K | 1,053,882 −2.1% of holding | |
| Stuka Paul | Director | Buy | 5,000 | $1.15 | $5.8K | 647,871 | |
| Stuka Paul | Director | Buy | 10,000 | $1.16 | $11.6K | 642,871 | |
| Slosman Marvin | CEO and President | Buy | 21,000 | $1.20 | $25.2K | 3,556,658 | |
| Stuka Paul 2 fills | Director | Buy | 20,000 | $1.19 | $23.8K | 632,871 | |
| Stuka Paul 2 fills | Director | Buy | 131,252 | $1.16 | $152.3K | 622,871 | |
| ROUBIN GARY S | Director | Buy | 90,000 | $1.18 | $106.2K | 834,478 | |
| Ward Scott R. | Director | Buy | 73,255 | $1.15 | $84.2K | 237,096 | |
| Stuka Paul | Director | Buy | 6,378 | $1.15 | $7.3K | 531,599 | |
| Ward Scott R. | Director | Buy | 15,995 | $1.15 | $18.4K | 163,841 | |
| Stuka Paul | Director | Buy | 1,517 | $1.12 | $1.7K | 525,221 | |
| Gleason Shane Thomas 2 fills | Chief Commercial Officer | Sell | 4,941 | $1.60 | $7.9K | 1,139,177 −0.4% of holding | |
| Gleason Shane Thomas | Chief Commercial Officer | Sell | 2,900 | $1.63 | $4.7K | 1,141,177 −0.3% of holding | |
| Gleason Shane Thomas | Chief Commercial Officer | Sell | 5,000 | $1.65 | $8.3K | 1,144,077 −0.4% of holding | |
| Gleason Shane Thomas | Chief Commercial Officer | Sell | 12,395 | $1.65 | $20.5K | 1,149,077 −1.1% of holding | |
| Gleason Shane Thomas | Chief Commercial Officer | Sell | 4,781 | $1.66 | $8.0K | 1,161,472 −0.4% of holding | |
| Gleason Shane Thomas | Chief Commercial Officer | Sell | 8,411 | $1.57 | $13.2K | 1,166,253 −0.7% of holding | |
| Gleason Shane Thomas | Chief Commercial Officer | Sell | 17,593 | $1.62 | $28.6K | 1,174,664 −1.5% of holding | |
| Gleason Shane Thomas | Chief Commercial Officer | Sell | 2,955 | $1.59 | $4.7K | 1,192,257 −0.2% of holding | |
| Gleason Shane Thomas | Chief Commercial Officer | Sell | 2,250 | $1.61 | $3.6K | 1,195,212 −0.2% of holding | |
| Gleason Shane Thomas | Chief Commercial Officer | Sell | 2,909 | $1.58 | $4.6K | 1,197,462 −0.2% of holding | |
| Stuka Paul 2 fills | Director | Buy | 7,783 | $1.81 | $14.1K | 391,628 | |
| Stuka Paul | Director | Buy | 5,073 | $1.86 | $9.4K | 388,918 | |
| Stuka Paul | Director | Buy | 10,130 | $1.85 | $18.7K | 383,845 | |
| Stuka Paul | Director | Buy | 13,431 | $1.62 | $21.8K | 373,715 |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.